Neogen CorporationNEOGNASDAQ
LOADING
|||
R&D Expense Growth Recovery in Progress
Trending higher, below historical average.
Left:
||||
Year-over-year research & development expense growth
Latest
-10.97%
↓ 518% below average
Average (39q)
2.63%
Historical baseline
Range
High:44.27%
Low:-31.10%
CAGR
+1.4%
Modest growth trend
| Period | Value |
|---|---|
| Q4 2025 | -10.97% |
| Q3 2025 | -18.74% |
| Q2 2025 | 41.00% |
| Q1 2025 | -12.43% |
| Q4 2024 | -1.75% |
| Q3 2024 | 1.05% |
| Q2 2024 | 6.02% |
| Q1 2024 | -15.69% |
| Q4 2023 | -14.37% |
| Q3 2023 | -4.71% |
| Q2 2023 | -2.81% |
| Q1 2023 | 6.02% |
| Q4 2022 | 40.26% |
| Q3 2022 | 27.41% |
| Q2 2022 | -16.01% |
| Q1 2022 | 5.29% |
| Q4 2021 | 0.16% |
| Q3 2021 | 6.08% |
| Q2 2021 | -3.75% |
| Q1 2021 | 4.44% |
| Q4 2020 | 4.59% |
| Q3 2020 | 12.15% |
| Q2 2020 | -9.55% |
| Q1 2020 | 1.11% |
| Q4 2019 | 2.52% |
| Q3 2019 | 3.31% |
| Q2 2019 | 9.88% |
| Q1 2019 | 2.59% |
| Q4 2018 | 12.34% |
| Q3 2018 | 44.27% |
| Q2 2018 | -31.10% |
| Q1 2018 | -4.42% |
| Q4 2017 | -4.23% |
| Q3 2017 | 34.81% |
| Q2 2017 | -12.99% |
| Q1 2017 | -4.59% |
| Q4 2016 | 3.36% |
| Q3 2016 | 19.13% |
| Q2 2016 | -8.28% |
| Q1 2016 | -6.38% |